These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6405769)

  • 21. Studies of vascular responses of feet of normal subjects to dihydrogenated ergot alkaloids and tolazoline under controlled conditions.
    SKOWLUND HV; KOTTKE FJ
    Arch Phys Med Rehabil; 1963 Mar; 44():157-66. PubMed ID: 13989109
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of bencyclane on blood circulation of the human calf muscle in the acute test using the 133-Xe tissue clearance method].
    Debröczi T; Horváth M; Ludvigh K
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1412+. PubMed ID: 5536656
    [No Abstract]   [Full Text] [Related]  

  • 23. [Capacitive vascular reactions of the skeletal musculature before and after adrenoreceptor blockade].
    Tkachenko BI; Kudriashov IuA; Ovsiannikov VI
    Fiziol Zh SSSR Im I M Sechenova; 1980 Feb; 66(2):181-8. PubMed ID: 7364118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of enalapril on leg muscle blood flow in patients with claudication.
    Sonecha TN; Nicolaides AN; Kyprianou P; Zukowski A; Papadakis K; Vasdekis S; Salmasi AM
    Int Angiol; 1990; 9(1):22-4. PubMed ID: 2212796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The time course and magnitude of blood flow changes in the human quadriceps muscles following isometric contraction.
    Wesche J
    J Physiol; 1986 Aug; 377():445-62. PubMed ID: 3795098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of ergot alkaloids on lipolysis and on glucagon-induced insulin secretion in normal and obese subjects].
    Bertolini S; Castello C; Astengo F; Risso M; Fuliano P; Fattorini A; Balestreri R
    Boll Soc Ital Biol Sper; 1977 Nov; 53(22):1989-97. PubMed ID: 603700
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacologic activity of dihydroergotoxine methanesulfonate and its constituents].
    Palamara G; De Luca G; Materazzi M
    Boll Chim Farm; 1978 May; 117(5):289-95. PubMed ID: 743377
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vivo antiaggregant activity of dihydroergotoxine].
    Manzanares J; Zaragozá F; Benedí J; Iglesias I
    Arch Farmacol Toxicol; 1986; 12(2-3):139-44. PubMed ID: 3619502
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood flow changes following brief concentric contractions of human calf muscles.
    Nagami K
    Tokai J Exp Clin Med; 1990 Mar; 15(1):35-44. PubMed ID: 2087704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Specificity and precision of a radioimmunoassay of dihydroergotoxine in plasma].
    Loh W; Woodcock BG
    Arzneimittelforschung; 1983; 33(4):568-70. PubMed ID: 6683536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of training on the muscle blood flow and heart rate].
    Treumann F; Schroeder W
    Z Kreislaufforsch; 1968 Nov; 57(11):1024-33. PubMed ID: 5710008
    [No Abstract]   [Full Text] [Related]  

  • 32. [The reactions of the capillary bed of the skeletal muscles to normobaric hyperoxia and a perfluoro-organic blood substitute].
    Golub' AS; Brod VI; Krivoshapkin AL
    Fiziol Zh Im I M Sechenova; 1993 Jan; 79(1):56-63. PubMed ID: 8518850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical pharmacology of dihydroergotoxine mesylate (Hydergine).
    James IM
    Br J Clin Pract Suppl; 1985 Jun; 39():21-4. PubMed ID: 3929811
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of dihydroergotoxine (Redergine) on the sleep-wakefulness cycle in the cat.
    Susić V; Masirević G
    Gerontology; 1979; 25(4):212-8. PubMed ID: 222649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of muscle blood flow in patients with arteritis, using the radioactive xenon method].
    Puel P; Enjalbert A; Gédéon A; Bru A
    Ann Chir Thorac Cardiovasc; 1967 Jul; 6(3):377-87. PubMed ID: 4897518
    [No Abstract]   [Full Text] [Related]  

  • 36. [Quantitative EEG examinations on the vigilance stabilizing effect of nicergoline / Results of a double blind study with gerontopsychiatric patients (author's transl)].
    Bente D; Glatthaar G; Ulrich G; Lewinsky M
    Arzneimittelforschung; 1979; 29(11):1804-8. PubMed ID: 543890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of long term administration of prazosin on the microcirculation in skeletal muscles.
    Dawson JM; Hudlická O
    Cardiovasc Res; 1989 Nov; 23(11):913-20. PubMed ID: 2611800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients.
    Vanrenterghem Y; Waer M; De Keyser P; Roels L; Michielsen P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):615-7. PubMed ID: 3291296
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of piracetam and dihydroergotoxine on the release of dopamine from the corpus striatum of the rat].
    Wustmann C; Rudolph E; Fischer HD; Dietze M; Schulze S
    Acta Biol Med Ger; 1980; 39(8-9):383-5. PubMed ID: 7282216
    [No Abstract]   [Full Text] [Related]  

  • 40. Absorption kinetics of dihydroergotoxine following oral administration to man.
    Woodcock BG; Rietbrock N; Loh W; Habedank WD
    Br J Clin Pharmacol; 1985 Dec; 20(6):603-9. PubMed ID: 4091992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.